AETC National Coordinating Resource Center

François-Xavier Bagnoud Center

Rutgers School of Nursing
65 Bergen Street, 8th floor
Newark, NJ 07101
United States

Phone
(973) 972-5141
Fax
(973) 972-0397

The AIDS Education and Training Center (AETC) National Coordinating Resource Center (NCRC) provides education, training, and capacity building resources for the AETC Program (8 regional centers, 2 national centers, the National HIV Curriculum, and special projects) to support the provision of timely, high quality, state-of-the-science information to healthcare professionals working with existing and emerging populations affected by HIV. The AETC NCRC functions within the AETC Program to provide:

  • National HIV training curricula
  • A virtual resource library
  • National AETC Program resource development
  • An AETC Program directory and event calendar
  • National AETC Program group coordination and collaboration
  • AETC Program marketing and communication services
  • Coordination and facilitation of the annual Ryan White HIV/AIDS Program Clinical Conference 
Principal Investigator
Phone: (973) 972-5141
Fax: (973) 972-0397
Program Director
Phone: (973) 972-6268
Fax: (973) 972-4263
Nurse Education Specialist
Phone: 973-972-8983
Marketing & Communications Coordinator
Phone: (973) 972-5528
Multimedia Designer II

Resources: 49

Title Publish Date Review Date Sort descending
Federal Training Centers Collaborative (FTCC) Virtual Learning Session Materials
Quick Guide: CDC HIV Laboratory Testing Recommendations
Increasing Viral Suppression among People with HIV with Mental Health Disorders Infographic
Rapid (Immediate) ART Initiation & Restart: Guide for Clinicians
Integrating Behavioral Health into Primary HIV Care — Covering the Bases
Stock Photo Library
HIV Epidemic Rapid Response Toolkit
Results and Response to a 10-State COVID-19 Practice Impact Survey in the Mountain West Region
U.S. Monkeypox (MPX) - Information and Recommendations
Best Practices for Finding and Crediting Images
Ryan White HIV/AIDS Program (RWHAP) Clinical Conference
HHS Adult ART Guidelines: Initial Therapy
New Pandemic, Old Inequities: Impacts of COVID-19 and HIV on Marginalized Populations
HIV Care Continuum: Key Resources for HIV Clinicians
HIV Health Outcomes: It’s More Than Just Viral Suppression
Non-Occupational Post-Exposure Prophylaxis (nPEP) Toolkit
HHS Adult ART Guidelines: Treatment-Experienced Patients
Community Health Worker Training Resources
Using Trauma-Informed Dental Care for People with HIV Infographic
Brand and Generic Names of ARVs in the United States and Mexico
HIV & SARS-CoV-2 Webinar Series
Risk, Presentation, Treatment, and Outcomes of COVID-19 in People with HIV
Tips for Managing Digital Design Projects
Clinician Mobile Apps for HIV-related Care
Barriers to Curing Hepatitis C Virus among Coinfected People with HIV Infographic
Prescribing PrEP: A Guide for Healthcare Providers
HHS Adult ART Guidelines: Transgender People with HIV
Post COVID Syndrome: An Overview and Approach to Management
HIV Care Conversations
Assisting HIV Patients Returning to Mexico and Central America / Asistiendo a los Pacientes que Regresan a México y Centroamérica
Evaluating AETC NCRC Partnerships for Impact
Implementing Substance Use Disorder (SUD) Services in HIV Care Settings Toolkit
Stock Image Website and Resource List
Reaching People with HIV in Rural United States
Direct-acting Antiviral (DAA) Prior Authorization Letter Templates
COVID-19, HIV, and Housing Instability
Resources for Accessibility
Flyer: Hepatitis C Screening and Treatment in People with HIV
Hep C Free Postcard
Passport to Cure
HIV/HCV Co-infection: An AETC National Curriculum
Self-care, Resiliency, and Stress Management for Healthcare Providers
Hepatitis C: Getting Cured Is Easier than Ever
Myths about Providing HCV Treatment to People with HIV with Substance Use Disorder(s)
Conducting a Primary or Acute Care HIV Telemedicine Visit
HHS Adult ART Guidelines: HIV and ART in Older People
AETC Program Interprofessional Education (IPE) Toolkit
Federal COVID-19 Resources
Resources for HRSA HAB Performance Measures

Articles: 40

Title Publish date Review date Sort descending
Naltrexone Improves Virologic Suppression
FDA Approves 2-Drug Combination of Dolutegravir + Lamivudine
AETC Representation at the 2022 National Ryan White Conference on HIV Care & Treatment
Updates in Antiretroviral Treatment during Pregnancy: Dolutegravir in Late Pregnancy
Switching from TDF/FTC to TAF/FTC
Bictegravir/TAF/FTC in Women
Safety of Dolutegravir at Conception: Updated Data
HIV Meds Update: Anal Dysplasia Treatment Prevents Anal Cancer - The ANCHOR Study
START-ing TEMPRANO: Early Initiation of Antiretroviral Therapy for HIV
HIV Meds Update - RAPID: Immediate ART Initiation
Dolutegravir + 3TC in Initial Therapy
Updates on Mpox: Vaccination Efficacy and Spectrum of Disease in People with HIV
Rifampin Drug-Drug Interactions with Newer Antiretrovirals (TAF, Bictegravir, Dolutegravir)
Darunavir/Cobicistat/FTC/TAF Single-Pill Combination in Treatment-Experienced Patients: EMERALD Study
PrEP: TDF/FTC vs TAF/FTC in MSM
Long-acting Injectable PrEP Approved: Cabotegravir
HIV-related Journal Articles from AETC-Affiliated Researchers and Faculty, 2022
Dolutegravir in Early Pregnancy: Updates on Possible Risk of Neural Tube Defects
PrEP: Bone Density Improves after Stopping TDF/FTC
Bictegravir Approved for Initial ART, in Combination with TAF/FTC
New ARV Approval - Fostemsavir
HIV Meds Update: FDA Approves Lenacapavir, New Long-Acting Injectable ARV
Efavirenz, Dolutegravir, and Darunavir: Pharmacokinetics during Pregnancy
Ibalizumab Approved for Persons with Multidrug Resistant HIV
Rapid ART Start
Tenofovir Alafenamide (TAF) and Darunavir/Cobicistat in Pregnant Women
Tissue Levels of TAF: Too Low for PrEP?
Immediate ART Initiation Improves Time to Viral Suppression
Long-Acting Injectable ART: Cabotegravir + Rilpivirine
Updated CDC PrEP Guidelines
HIV-related Journal Articles from AETC-Affiliated Researchers and Faculty, 2023
HIV Meds Update: ART in Acute HIV--Decreasing HIV DNA
Darunavir/Cobicistat/FTC/TAF Coformulation Approved; More Data from EMERALD Switch Study
Long-acting Injectable PrEP: Cabotegravir
HIV Meds Update: DoxyPEP – Doxycycline for STI Prevention
Use of Dolutegravir in Dialysis
HIV Meds Updates: Long-acting Injectable Therapy: Lenacapavir
HIV Meds Updates - TANGO and SALSA Studies: Switch to DTG/3TC from 3-Drug ART
HIV Meds Updates - Long-acting Injectable Therapy: Cabotegravir + Rilpivirine
HIV Care Tools – A New Resource for Ending the HIV Epidemic